Source: Genomeweb

Spartan Bioscience: Canada's Spartan Bioscience Reemerges as Genomadix With Eye Toward Near-Patient COVID-19 Testing

The firm is now moving forward on COVID-19 molecular diagnostic clinical trials in the US with the hopes of obtaining FDA Emergency Use Authorization.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Roger Eacock's photo - CEO of Spartan Bioscience

CEO

Roger Eacock

CEO Approval Rating

84/100

Read more